Half of workers may struggle to get obesity drug insurance coverage

Half of workers may struggle to get obesity drug insurance coverage

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Companies are increasing access to new blockbuster weight-loss drugs for employees, but size of employer may make a big difference in early access. Small businesses and their workers are often stuck … Read more

Jim Cramer identifies 5 stocks that are buys right here, right now

Jim Cramer identifies 5 stocks that are buys right here, right now

Let’s say you just joined the Club, and you are trying to figure out which stocks we think are buyable right now, right here. Ideally, what I would like members to be thinking about is a companion portfolio of up to a dozen stocks to a market index fund position — something we recommend for … Read more

AI cancer screening is booming, most not covered by insurance

AI cancer screening is booming, most not covered by insurance

Artificial intelligence for cancer screening has taken off. Yet most of those new programs aren’t covered by Medicare or private insurers, which creates headwinds for companies looking to boost adoption and for patients who could benefit from the new technology.   “Traditionally, for medical devices it takes up to seven years after a product that’s … Read more

Nestle CEO discusses impact of weight loss drugs on food industry

Nestle CEO discusses impact of weight loss drugs on food industry

A picture taken on February 21, 2024 show the logo of Swiss food giant Nestle on the company’s headquarters in Vevey, western Switzerland. Fabrice Coffrini | Afp | Getty Images The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides new opportunities for food companies, Nestle CEO Mark Schneider told … Read more

Wells Fargo CEO talks up reasons to love the stock — plus, why the market drop

Wells Fargo CEO talks up reasons to love the stock — plus, why the market drop

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market pressure : The major stock benchmarks were moving lower Wednesday, with the Dow getting the worst of it again. Adding pressure on equities, bond yields … Read more

Ro launches GLP-1 supply tracker to help patients navigate shortages

Ro launches GLP-1 supply tracker to help patients navigate shortages

GLP-1 Supply Tracker from Ro.  Courtesy: Ro Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S. The supply tracker could be a valuable tool for many Americans scrambling to get their hands … Read more

Why Walmart, Walgreens, CVS health clinic experiment is struggling

Why Walmart, Walgreens, CVS health clinic experiment is struggling

Bobbi Radford showed up at the CVS MinuteClinic in Batavia, Ohio, last Thanksgiving because she had pain in her arm. “I waited an hour and then was told to go to the [emergency room].,” Radford said. Filling the staffer in on her history of congestive heart failure, she was directed to go to the ER. But Radford says after she did … Read more

Neuralink competitor Precision Neuroscience testing human brain implant

Neuralink competitor Precision Neuroscience testing human brain implant

Dr. Joshua Bederson places Precision Neuroscience’s electrodes onto a brain. Ashley Capoot As the lights dimmed in an operating room at The Mount Sinai Hospital in New York City, Dr. Joshua Bederson prepared to make history. Bederson, system chair for the Department of Neurosurgery at Mount Sinai Health System, is no stranger to long hours … Read more

Digital health companies are launching programs around GLP-1s

Digital health companies are launching programs around GLP-1s

Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and is at least twice as effective — is expected to expire by the decade’s end. Michael Siluk | UCG | Getty Images For Gray Beard, a kindergarten teacher in Charlotte, North Carolina, losing weight had … Read more

Eli Lilly big GLP-1 investment — plus, CRM, BBY, FL, COST earnings next week

Eli Lilly big GLP-1 investment — plus, CRM, BBY, FL, COST earnings next week

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Wall Street was bouncing higher Friday after, as Jim Cramer put it, a “really bad day” in the prior session. Thursday’s late-day decline happened as bond yields rose on … Read more